Edition:
United States

People: Santen Pharmaceutical Co Ltd (4536.T)

4536.T on Tokyo Stock Exchange

1,619JPY
27 May 2016
Change (% chg)

-- (--)
Prev Close
¥1,619
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,729,228
52-wk High
¥2,163
52-wk Low
¥1,519

Summary

Name Age Since Current Position

Akira Kurokawa

63 2008 President, Chief Executive Officer, Representative Director

Kazuo Koshiji

2015 Chief Financial Officer, Managing Executive Officer, Chief Director of Finance

Sadatoshi Furukado

61 2014 Executive Vice President, Director

Noriaki Yamamoto

Chief Information Officer, Executive Officer, Chief Director of Information System

Naveed Shams

Chief Scientific Officer, Managing Executive Officer, Chief Director of Research & Development, President & Chief Executive Officer of Subsidiary

Takeshi Ito

Managing Executive Officer, Director of Pharmaceutical Business

Atsutoshi Ohta

Managing Executive Officer, Chief Director of Human Resources Development

Masamichi Sato

2012 Managing Executive Officer, Chief Director of CSR & Operation

Akihiro Tsujimura

2015 Managing Executive Officer, Director of Asia Business

Hiroyuki Yamazaki

Executive Officer, Senior Director of Pharmaceutical Sales in Pharmaceutical Business Unit

Akio Kimura

2011 Executive Officer, Chief Director of Reliability Guarantee

Jyrki Liljeroos

Executive Officer, President of Subsidiary

Kenji Morishima

2011 Executive Officer, Senior Director of Global Pharmaceutical Technology in Main Research & Development Unit

Keizo Nakada

Executive Officer, Chief Director of Product Supply

Shigeo Taniuchi

Executive Officer, President of Subsidiary

Takayuki Katayama

69 2012 Independent Director

Kanoko Ohishi

54 2015 Independent Director

Akihiro Okumura

69 2011 Independent Director

Shiro Hatagami

2015 Manager of Finance & Accounting Group

Biographies

Name Description

Akira Kurokawa

Mr. Akira Kurokawa has been serving as President, Chief Executive Officer and Representative Director in SANTEN PHARMACEUTICAL CO., LTD. since June 25, 2008. He joined the Company in April 1977. His previous titles include Director of Pharmaceutical Business, Managing Executive Officer and Chief Operating Officer in the Company.

Kazuo Koshiji

Sadatoshi Furukado

Mr. Sadatoshi Furukado has been serving as Executive Vice President and Director in SANTEN PHARMACEUTICAL CO., LTD. since April 2014. He joined the Company in April 1977 and used to serve as Senior Director of Medicine Sales, Executive Officer and Managing Executive Officer.

Noriaki Yamamoto

Naveed Shams

Takeshi Ito

Atsutoshi Ohta

Masamichi Sato

Akihiro Tsujimura

Hiroyuki Yamazaki

Akio Kimura

Jyrki Liljeroos

Kenji Morishima

Keizo Nakada

Shigeo Taniuchi

Takayuki Katayama

Mr. Takayuki Katayama has been serving as Independent Director in SANTEN PHARMACEUTICAL CO., LTD. since June 2012. He is also working for Teijin Limited and Toyo Seikan Group Holdings, Ltd. He used to be Vice President and Representative Director in Teijin Limited.

Kanoko Ohishi

Ms. Kanoko Ohishi has been serving as Independent Director in SANTEN PHARMACEUTICAL CO., LTD. since June 2015. She is also serving as Representative Director in Mediva Inc. and another company, and working for Medical Corporation Platanus. She used to work for McKinsey & Company, Inc. and Astellas Pharma Inc.

Akihiro Okumura

Mr. Akihiro Okumura has been serving as Independent Director in SANTEN PHARMACEUTICAL CO., LTD. since June 2011. He is also working for University of Shizuoka and Keio University.

Shiro Hatagami